Skip to main content
Equibles
BWXT logo

BWXT · BWX Technologies, Inc.

Track BWXT — free

Use BWXT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BWXT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$123.18 -8.64 (-6.55%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$12.08B
Shares
91.63M
Volume · Nov 4 2.31M Avg daily vol (3M) 1.14M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$121.50 Open$127.00 Day$119.60–129.08 52W close$121.50–238.42 Avg vol 30d1.2M Short int3.4M · 3.7% of shares · 2.6d Short vol30% Last earningsNov 2, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 2

Up next

Next earnings call
Feb 1, 2027 Est · unconfirmed · in 13 wks
Q3 2026 earnings call transcript
call held Nov 2, 2026
Play latest call

Latest documents

2026
Nov 4
Current report 8-K
Other events AI summary on its way
Nov 2
Earnings call
Q3 2026 earnings call

BWX Technologies reported third-quarter revenue of $953 million and adjusted EBITDA of $180 million, up 19%. It raised 2026 free cash flow guidance to $350 million to $360 million.

Nov 2
Current report 8-K Events of Sep 30
Financial results

BWX Technologies reported third-quarter 2026 revenue of $953.0 million and adjusted EBITDA of $179.7 million, and tightened 2026 non-GAAP EPS guidance to $4.72-$4.77 and free cash flow guidance to $350 million-$360 million.

Nov 2
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

BWX Technologies reported nine-month revenues of $2,714.8 million and operating income of $352.9 million through September 30, 2026; backlog was $8,556.2 million, and the medical business sale to Nordic Capital is valued at up to $800 million.

Revenue $952.97M ▲ 10.0% Net income $101.71M ▲ 23.9% Diluted EPS $1.11 ▲ 24.7%
Read from the MD&A section
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.60B
Trailing 12 months
Net income (TTM)
$374.78M
Trailing 12 months
Revenue growth YoY
+10.0%
Year over year
Operating margin
12.4%
Trailing 12 months
P / E (TTM)
32.3
Trailing earnings · reciprocal yield 3.1%
FCF yield
3.1%
TTM · current market cap
Return on invested capital
13.4%
Trailing 12 months
Net cash
−$1.52B
Latest balance sheet
Dividend yield
0.8%
Trailing 12 months
Shares change YoY
+0.2%
Year over year · more shares
Price change (1Y)
-38.9%
Trailing year
Short interest
3.7%
Latest settlement · 2.6 days to cover
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲2.9% $746.27M $71.02M '24 Q4 ▲13% $682.26M $75.46M '25 Q1 ▲12.1% $764.04M $78.39M '25 Q2 ▲28.9% $866.29M $82.11M '25 Q3 ▲18.7% $885.84M $92.99M '25 Q4 ▲26.1% $860.22M $91.07M '26 Q1 ▲18% $901.62M $89.01M '26 Q2 LATEST ▲10% $952.97M $101.71M '26 Q3

Mentioned in fund letters

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 20.8 · elevated Equity put/call 0.60
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −34%
below
Price vs 50-day avg −14%
below
RSI (14) 33
neutral
MACD trend Negative
52-week position 0%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −14%
trailing
6-month return −42%
trailing
YTD return −30%
this year
Relative strength −45%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $142 › 200d $184 — 200d above 50d
Institutional flow Accumulating
349 of 864 funds reported for Sep 30 · net +146.2K sh shares · +43 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.68% of shares out · ▲ +2.6% MoM · 2.6 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
864 holders — near 3-yr high, broad support
Squeeze score 62
elevated · 0–100
Fundamentals
Excellent
Revenue growth +9%
Y/Y
EPS growth +17%
Y/Y
Free cash flow $295.3M
Valuation P/E 32.3
below peers
Buyback $347.6M
remaining
Balance sheet $1.5B
net debt
Quant / Vol
risk profile
Very High
Volatility 45%
annualized · 1-yr
Max drawdown −49%
past year
ATR 4.8%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 5 of last 6
Latest guidance · from the 8-K filed Nov 2, 2026
Revenue · Year Ending December 31, 2026 Maintained $3.8B
Aug 3, 2026 $3.8B changed to Nov 2, 2026 $3.8B
prior FY $3.2B midpoint +18.8% Y/Y
Adjusted EBITDA(1) · Year Ending December 31, 2026 Non-GAAP Maintained $667M
Aug 3, 2026 $662M – $672M changed to Nov 2, 2026 $667M
Non-GAAP(1) Earnings Per Share · Year Ending December 31, 2026 Non-GAAP Lowered $4.72 – $4.77
Aug 3, 2026 $4.70 – $4.80 changed to Nov 2, 2026 $4.72 – $4.77
Free Cash Flow(1) · Year Ending December 31, 2026 Non-GAAP $350M – $360M
Previous outlook earlier release · from the 8-K filed Feb 23, 2026

Still-open targets the latest release did not restate under the same label.

Revenue · Year Ending December 31, 2026 $3.75B
Guided vs delivered · last 6 settled
Revenue Year Ending December 31, 2025
guided at least $3.1B
$3.2B In line
Revenue Year Ending December 31, 2024
guided at least $2.6B
$2.7B In line
Revenue Year Ending December 31, 2023
guided $2.4B
$2.5B Beat +4.0%
EPS 2022
guided $3.05 – $3.25
$2.60 Miss −17.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 3 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−34% Bearish
Price vs 50-day avg
−14% Bearish
RSI (14)
33 Neutral
MACD trend
Negative Bearish
52-week position
0% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $142 › 200d $184 — 200d above 50d
Institutional flow Accumulating
349 of 864 funds reported for Sep 30 · net +146.2K sh shares · +43 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.68% of shares out · ▲ +2.6% MoM · 2.6 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
864 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $122 Now $122 · 0% Range high $238
vs 200-day avg -34% vs 50-day avg -14%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Backlog (Commercial Operations) 1.6B June 30, 2026 —
Backlog (Government Operations) 6.8B June 30, 2026 —
Bookings (Commercial Operations) 181.25M Three Months Ended June 30, 2026 —
Bookings (Government Operations) 467.62M Three Months Ended June 30, 2026 —
Commercial Operations Adjusted EBITDA non-GAAP $36.1M Three Months Ended June 30, 2026 —
Consolidated non-GAAP Operating Income non-GAAP $126.6M Three Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net Cash Provided By Operating Activities 156.4M
-41.4M Purchases of Property, Plant and Equipment
= Free Cash Flow 115M
Non-GAAP EPS (Diluted) non-GAAP $1.07 2Q26 —
GAAP → non-GAAP reconciliation
GAAP Diluted Earnings per Common Share $0.97
+$0.05 Restructuring & Transformation Costs
+$0.03 Acquisition-Related Costs
+$0.02 Acquisition-Related Amortization
= Non-GAAP Diluted Earnings per Common Share $1.07
Non-GAAP Net Income non-GAAP $98.6M Three Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Net Income 89.1M
+4.8M Restructuring & Transformation Costs
+2.9M Acquisition-Related Costs
+1.9M Acquisition-Related Amortization
= Non-GAAP Net Income 98.6M
Non-GAAP Operating Income non-GAAP 126.5M Three Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Operating Income 114.1M
+6.2M Restructuring & Transformation Costs
+3.7M Acquisition-Related Costs
+2.5M Acquisition-Related Amortization
= Non-GAAP Operating Income 126.5M
Non-GAAP Operating Income (Commercial Operations) non-GAAP 28.7M Three Months Ended June 30, 2026 —
GAAP → non-GAAP reconciliation
GAAP Commercial Operations Operating Income 24.3M
+2.1M Restructuring & Transformation Costs
+0.8M Acquisition-Related Costs
+1.5M Acquisition-Related Amortization
= Non-GAAP Operating Income - Commercial Operations 28.7M
Non-GAAP Operating Income (Government Operations) non-GAAP 106.8M Three Months Ended June 30, 2026 —
Total Backlog 8.4B June 30, 2026 —
Total Bookings 648.87M Three Months Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Aerospace & Defense — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
BWXT
BWX Technologies, Inc.
this stock
$12.08B -29.7% +8.8% 32.3 3.7%
SPCX
Space Exploration Technologies Corp
 $1.82T — — — 1.2%
GE
General Electric Co
 $331.36B +7.0% +18.5% 37.0 1.1%
RTX
RTX Corp
 $266.33B +8.2% +17.1% 32.0 1.0%
EADSF
Airbus SE
 $169.89B -7.8% — — 0.1%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
832
% held
96.1%
Reported
349 of 864
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
594
View
Short & Settlement
Short Interest Rising
Shares short
3.4M
Days to cover
2.6d
Change
+85.6K sh
View
Short Volume
Short vol %
30%
As of
Nov 4, 2026
Short Total
View
Fails to Deliver
FTD shares
1.0K
Value
$149.7K
As of
Sep 18, 2026
View
Off-Exchange
Off-exchange %
49.4%
Week of
Sep 28, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
April McClain Delaney
Amount
$100.0K–$250.0K
Traded
Aug 25, 2026
View
Financials
Financials
Revenue (FY)
$3.2B
Net income (FY)
$328.9M
EPS diluted
$3.58
View
Buybacks
Authorized
$500.0M
Remaining
$347.6M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Nov 4, 2026
This year
17
View
Proposed Sales
Value
$1.7M
Shares
10.0K
Filed
Aug 12, 2026
View
Earnings & Events
Webcasts
Last webcast
Nov 2, 2026
View

Performance

5D 20D 120D MTD YTD
BWXT -10.0% -14.2% -42.4% -7.0% -29.7%
SPY -0.7% -1.3% +2.5% +1.5% +12.5%
vs SPY -9.3% -12.8% -44.9% -8.5% -42.2%

Capital returns

Latest dividend
$0.27 / share · ex Aug 18, 2026
Declared · upcoming
$0.27 / share · ex Nov 19, 2026
Raised 8%
Paid (TTM)
$1.06 / share · 4 payouts
Dividend yield (TTM, derived)
0.87%
Full dividend history
Buyback program · as of Dec 31, 2025
Authorized
$500.00M
Spent (derived)
$152.40M
Remaining
$347.60M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1486957 CUSIP 05605H100 13F (30d) 295 filings 273 filers Visit website Investor relations